Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axolabs is a leading global CRDMO specializing in the discovery, development, analytics, and GMP manufacturing of DNA/RNA-based therapeutics. It offers integrated solutions for oligonucleotide drug development—including lead identification/optimization using proprietary bioinformatics tools, preclinical safety/pharmacokinetics studies with advanced analytical methods, process scale-up to GMP production for clinical trials and initial commercialization. The company has over 200 employees across sites in Germany and the US. It is recognized for its expertise in nucleic acid chemistry/analytics and strategic partnerships with technology providers such as Bruker and Asahi Kasei Bioprocess
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axolabs.